This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gonzalez-Ruiz, A Articles by Warhurst, D C Search for Related Content PubMed PubMed Citation Articles by Gonzalez-Ruiz, A Articles by Warhurst, D C

A monoclonal antibody for distinction of invasive and noninvasive clinical isolates of Entamoeba histolytica.

Department of Medical Parasitology, London School of Hygiene and Tropical Medicine, United Kingdom.

ABSTRACT

Approximately 10% of the world population is infected with Entamoeba histolytica, but only 10% of the carriers develop symptomatic amebiasis. This discrepancy could be explained by the genotypic differences between the morphologically indistinguishable invasive and noninvasive strains of E. histolytica currently identified by zymodeme analysis, a technique that is unsuitable for routine diagnostic laboratories. Here we report the production of a monoclonal antibody against E. histolytica and its use in an immunofluorescence assay to identify invasive isolates cultured from stool samples of infected patients in several regions where amebiasis is endemic: Bangladesh, Colombia, and Mexico. After testing a total of 88 E. histolytica isolates, the correlation between zymodeme characterization and the immunofluorescence assay with the invasive isolate-specific monoclonal antibody was 100%. The epitope detected by the invasive isolate-specific monoclonal antibody resides in a previously undescribed internal protein with molecular masses of 84 and 81 kDa in axenic and polyxenic E. histolytica strains, respectively.

This article has been cited by other articles:

• Gonin, P., Trudel, L. (2003). Detection and Differentiation of Entamoeba histolytica and Entamoeba dispar Isolates in Clinical Samples by PCR and Enzyme-Linked Immunosorbent Assay. J. Clin. Microbiol. 41: 237-241 [Abstract] [Full Text]  
• Tachibana, H., Cheng, X.-J., Watanabe, K., Takekoshi, M., Maeda, F., Aotsuka, S., Kaneda, Y., Takeuchi, T., Ihara, S. (1999). Preparation of Recombinant Human Monoclonal Antibody Fab Fragments Specific for Entamoeba histolytica. CVI 6: 383-387 [Abstract] [Full Text]